Multiple myeloma: a review of the epidemiologic literature - PubMed

Affiliations

• PMID: 17405120
• DOI: 10.1002/ijc.22718

Review

Multiple myeloma: a review of the epidemiologic literature

Dominik D Alexander et al. Int J Cancer. 2007.

Abstract

Multiple myeloma, a neoplasm of plasma cells, accounts for approximately approximately 15% of lymphatohematopoietic cancers (LHC) and 2% of all cancers in the US. Incidence rates increase with age, particularly after age 40, and are higher in men, particularly African American men. The etiology is unknown with no established lifestyle, occupational or environmental risk factors. Although several factors have been implicated as potentially etiologic, findings are inconsistent. We reviewed epidemiologic studies that evaluated lifestyle, dietary, occupational and environmental factors; immune function, family history and genetic factors; and the hypothesized precursor, monoclonal gammopathies of undetermined significance (MGUS). Because multiple myeloma is an uncommon disease, etiologic assessments can be difficult because of small numbers of cases in occupational cohort studies, and few subjects reporting exposure to specific agents in case-control studies. Elevated risks have been reported consistently among persons with a positive family history of LHC. A few studies have reported a relationship between obesity and multiple myeloma, and this may be a promising area of research. Factors underlying higher incidence rates of multiple myeloma in African Americans are not understood. The progression from MGUS to multiple myeloma has been reported in several studies; however, there are no established risk factors for MGUS. To improve our understanding of the causes of multiple myeloma, future research efforts should seek the causes of MGUS. More research is also needed on the genetic factors of multiple myeloma, given the strong familial clustering of the disease.

Similar articles

• An update on molecular biology and drug resistance mechanisms of multiple myeloma.

  Mutlu P, Kiraz Y, Gündüz U, Baran Y. Mutlu P, et al. Crit Rev Oncol Hematol. 2015 Dec;96(3):413-24. doi: 10.1016/j.critrevonc.2015.07.003. Epub 2015 Jul 16. Crit Rev Oncol Hematol. 2015. PMID: 26235594 Review.

• Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.

  Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR. Landgren O, et al. Int J Cancer. 2006 Jun 15;118(12):3095-8. doi: 10.1002/ijc.21745. Int J Cancer. 2006. PMID: 16395700

• Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.

  Grass S, Preuss KD, Ahlgrimm M, Fadle N, Regitz E, Pfoehler C, Murawski N, Pfreundschuh M. Grass S, et al. Lancet Oncol. 2009 Oct;10(10):950-6. doi: 10.1016/S1470-2045(09)70234-7. Epub 2009 Sep 18. Lancet Oncol. 2009. PMID: 19767238

• Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.

  Iwanaga M, Tomonaga M. Iwanaga M, et al. Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):18-20. doi: 10.1016/j.clml.2013.12.010. Epub 2013 Dec 19. Clin Lymphoma Myeloma Leuk. 2014. PMID: 24461807

• Myeloma aetiology and epidemiology.

  Morgan GJ, Davies FE, Linet M. Morgan GJ, et al. Biomed Pharmacother. 2002 Jul;56(5):223-34. doi: 10.1016/s0753-3322(02)00194-4. Biomed Pharmacother. 2002. PMID: 12199621 Review.

Cited by

• Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium.

  Schinasi LH, Brown EE, Camp NJ, Wang SS, Hofmann JN, Chiu BC, Miligi L, Beane Freeman LE, de Sanjose S, Bernstein L, Monnereau A, Clavel J, Tricot GJ, Atanackovic D, Cocco P, Orsi L, Dosman JA, McLaughlin JR, Purdue MP, Cozen W, Spinelli JJ, de Roos AJ. Schinasi LH, et al. Br J Haematol. 2016 Oct;175(1):87-101. doi: 10.1111/bjh.14199. Epub 2016 Jun 22. Br J Haematol. 2016. PMID: 27330041 Free PMC article.

• Racial/ethnic differences in cancer risk after kidney transplantation.

  Hall EC, Segev DL, Engels EA. Hall EC, et al. Am J Transplant. 2013 Mar;13(3):714-20. doi: 10.1111/ajt.12066. Epub 2013 Jan 17. Am J Transplant. 2013. PMID: 23331953 Free PMC article.

• Inherited predisposition to multiple myeloma.

  Koura DT, Langston AA. Koura DT, et al. Ther Adv Hematol. 2013 Aug;4(4):291-7. doi: 10.1177/2040620713485375. Ther Adv Hematol. 2013. PMID: 23926460 Free PMC article.

• Multiple myeloma with concurrent immune thrombocytopenic purpura.

  Sarfraz H, Anand K, Liu S, Shah S. Sarfraz H, et al. Ecancermedicalscience. 2020 Feb 20;14:1012. doi: 10.3332/ecancer.2020.1012. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32256695 Free PMC article.

• Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.

  Shimanovsky A, Alvarez Argote J, Murali S, Dasanu CA. Shimanovsky A, et al. BBA Clin. 2016 May 25;6:12-8. doi: 10.1016/j.bbacli.2016.05.004. eCollection 2016 Dec. BBA Clin. 2016. PMID: 27331023 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Medical

  • MedlinePlus Health Information